Cabaletta Bio Inc

NAS:CABAHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$1.61+8.78%At closeAt close · Wed 21 Oct · ≈ AED 5.91 · Market cap $272.97M · Next earnings Thu 5 Nov · Extended $1.63 +1.24%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−30.4%	−39.2%	−50.7%	−28.7%	−76.1%	−149.8%	−149.8%	+0.0 pts
Return on assets	−29.1%	−36.6%	−45.3%	−26.7%	−62.6%	−101.7%	−101.7%	+0.0 pts
Return on capital employed	−30.9%	−39.3%	−50.4%	−31.4%	−79.2%	−149.9%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.1×	0.2×	0.2×	+0.0%
Debt / assets	0.0%	0.0%	4.4%	2.0%	8.4%	16.4%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	−167.3×	−85.9×	—	—
Current ratio	21.9×	14.9×	11.5×	15.3×	6.2×	2.8×	2.8×	+0.0%
Quick ratio	21.9×	14.9×	11.5×	15.3×	6.2×	2.8×	—	—
Cash ratio	19.6×	14.6×	8.6×	12.1×	6.1×	1.7×	1.7×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—